Ten63 Therapeutics
PrivateLast Round
Strategic
Feb 19, 2026
Total Funding Raised
$72.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ten63 Therapeutics is a biotechnology company that develops small molecule therapeutics for challenging disease targets, primarily in oncology, using its proprietary AI-driven drug discovery platform, BEYOND.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ten63 Therapeutics Comparables
Compare Ten63 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qubit Pharmaceuticals | 86% | |
| Genesis Molecular AI | 84% | |
| Aqemia | 82% | |
Ten63 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Feb 19, 2026 | ||||
| Strategic | Feb 19, 2026 | ||||
| Series A | May 2, 2023 | ||||
| Seed | Jan 27, 2021 | ||||
| Accelerator | Jun 25, 2019 | ||||
Seed | Apr 5, 2019 |
Key People
Founding team and executive leadership
Ten63 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hatteras Venture Partners | Strategic, Series A |
| Gates Foundation | Strategic |
| Chugai Venture Fund | Strategic |
| RYSE Asset Management | Strategic |
| Panorama Point Partners | Strategic |
| K5 Global | Strategic |
| Bill & Melinda Gates Foundation | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 7, 2.1x the trailing average.
- Jul 13, 2026
Open roles increased from 0 to 5, representing 16% of headcount.
Ten63 Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ten63 Therapeutics's valuation, stock price, and market status.